The lipid composition of germ cell membranes is considerably modi®ed during spermatogenesis, sperm maturation and capacitation. Some of these modi®cations are caused by exchanges between soluble lipid donors or acceptors and cell membranes. The aim of this study was to assess whether signi®cant lipid transfers between lipoprotein structures are detectable in human seminal plasma. Phospholipid and cholesteryl ester (CE) transfer activities were measured by speci®c¯uorescence and isotopic assays. Seminal plasma samples did not display signi®cant CE transfer. Substantial levels of phospholipid transfer activity were detected in all samples studied, levels were~25% of the phospholipid transfer activity measured in human blood plasma. Concordantly, CE transfer protein was not detected in seminal plasma, while the presence of the phospholipid transfer protein (PLTP) was con®rmed by Western blot analysis. Enzyme-linked immunosorbent assay indicated that seminal PLTP concentrations represented 25% of the concentration measured in blood plasma. Blockade of phosphatidylcholine and phosphatidyl-ethanolamine transfer by a 60 min, 56°C heating step or with anti-PLTP antibody revealed that PLTP accounts for almost 80% of the phospholipid transfer activity present in seminal plasma. As shown by gel-permeation chromatography and Western blot analysis, seminal PLTP activity was partially associated with prostasomes. Signi®cantly higher PLTP activity levels were measured in seminal plasma samples with low seminal vesicle secretions. The latter observation may re¯ect the sustained secretion of active PLTP that is diluted in a variable volume of PLTP-free seminal vesicle secretion. In conclusion, human seminal plasma displays signi®cant phospholipid transfer activity due to the presence of active PLTP.
Introduction
Spermatozoa are surrounded by a limiting plasma membrane that mediates many of the early events of the fertilization process. Spermatozoa membranes, that derive from spermatogonia and spermatocytes, are considerably modi®ed through changes in their cholesterol and phospholipid composition during spermatogenesis, sperm maturation and capacitation (Martõ Ânez and Morros, 1996; Nolan and Hammerstedt, 1997; Cross, 1998; Jones, 1998; Flesch and Gadella, 2000; Flesch et al., 2001) . Some of these modi®cations are caused by exchanges between cell membranes and lipid donors or acceptors, raising a considerable interest in identifying the factors that may catalyse lipid transfer in seminal plasma. Recently, human epididymal protein-1 (HE-1), a soluble protein secreted by epididymis in humans and other species, was shown to bind free cholesterol speci®cally with high af®nity. It might be involved in regulation of the lipid composition of the sperm membrane (Kirchhoff et al., 1996; Okamura et al., 1999; Fouchecourt et al., 2000) . Other recent studies support a role for seminal plasma phospholipid-binding proteins in mediating the sperm membrane lipid modi®cations (Desnoyers and Manjunath, 1992; Moreau et al., 1999; Manjunath and Therien, 2002) . These single chain, acidic polypeptides, also called bovine seminal plasma (BSP) proteins, are secreted by seminal vesicles, and bind to the sperm surface at ejaculation, stimulating rapid cholesterol ef¯ux in a concentration-dependent manner (Desnoyers and Manjunath, 1992; Moreau et al., 1999; Manjunath and Therien, 2002) . These proteins are well characterized in bovine seminal plasma and the presence of similar proteins in human seminal plasma and in other species has been reported (Leblond et al., 1993) . Members of the lipid transfer/ lipopolysaccharide-binding protein (LT/LBP) family, in particular cholesteryl ester transfer protein (CETP) and phospholipid transfer protein (PLTP), are also involved in lipid exchanges in some extracellular¯uids. In blood plasma, CETP promotes the exchange of neutral lipids, i.e. cholesteryl esters (CEs) and triglycerides between different lipoprotein classes (Drayna et al., 1987; Bruce et al., 1998a; 1998b) . PLTP was ®rst described as a plasma factor that facilitates the transfer of phospholipid between lipoproteins but recent studies have reported that PLTP can also exchange a number of other amphipathic compounds including unesteri®ed cholesterol, lipopolysaccharides, diacylglycerol and a-tocopherol (Lagrost et al., 1998; Van Tol, 2002) . In addition to their implication in inter-lipoprotein lipid exchanges, both CETP and PLTP were proven to catalyse lipid transfers between lipoproteins and cells, not only in blood plasma but also in other compartments including human cerebrospinal¯uid in the case of PLTP (Demeester et al., 2000) and human follicular¯uid in the case of CETP (Ravnik et al., 1992) . Interestingly, CETP was shown to stimulate sperm cell capacitation (Ravnik et al., 1990; Ravnik et al., 1992) . The aim of the present study was to search for the presence of lipid transfer activities in seminal plasma and to assess whether theses activities can be related to the presence of PLTP and CETP. To this end we measured CE and phospholipid transfer activities in seminal plasma samples from either healthy volunteers or men consulting at the centre of sterility. The presence of CETP and PLTP was investigated by Western blot analysis using speci®c monoclonal antibodies. Lipid transfer activities were also analysed in relation to the main markers of accessory glands, i.e. fructose, zinc, aglucosidase, as well as the number of sperm cells.
Materials and methods

Ethics
Investigations were conducted in accordance with the World Medical Association Declaration of Helsinki ethical principles for medical research involving human subjects. All patients gave informed written consent.
Samples
Human semen samples were obtained by masturbation from four healthy volunteers and were used for Western blot analysis, time-dependent lipid transfer activities and gel-permeation chromatography. For determining mean PLTP activities, mean PLTP concentrations and the association of PLTP with seminal plasma parameters, semen samples were obtained from 51 men consulting at the centre of sterility (Dijon, Ho Ãpital du bocage) after 3±5 days of sexual abstinence. Ejaculates were allowed to liquefy at 37°C for at least 30 min. After liquefaction, standard semen parameters were obtained according to the World Health Organization guidelines (World Health Organization, 1999) . The 51 men were subdivided according to their spermiogramms (as recommended by World Health Organization, 1999): normozoospermia (n = 16), oligozoospermia (n = 10), asthenozoospermia (n = 28), teratozoospermia (n = 22) and oligoasthenoteratospermia (n = 7). Blood samples were collected from volunteers into sterile lithium-heparinate containing tubes and immediately centrifuged at 3000 g for 15 min at 4°C.
Biochemical analysis
Seminal plasma samples were centrifuged at 3000 g for 10 min within 2 h after sampling. The supernatant was carefully removed and stored at ±20°C before biochemical analysis. Zinc in seminal plasma samples was measured by a colorimetric assay using 1-(2-pyridylazo)-2-naphtol (Fuentes et al., 1982) . Fructose and alpha-glucosidase activity were determined using commercially available kits (Roche Diagnostics S.A., Meylan, France). Cholesterol and protein concentrations were measured using commercially available kits on a Cobas Integra 700Ô analyser (Cobas Integra total cholesterolÔ Ref. 
Measurement of CE transfer activity
Fluorescence assay CE transfer activity was measured with a commercially available¯uorescence assay using synthetic liposomes enriched with nitrobenz-oxadiazol (NBD)-labelled CEs and very low-density lipoprotein (VLDL) (Roar Biomedical, New York, USA). The¯uorescent CE is present in a self-quenched state in the core of the donor. The CETP-mediated transfer is determined by the increase in uorescence intensity as the¯uorescent CE is removed from the self-quenched donor and transferred to the acceptor particle. Brie¯y, plasma samples (5 ml), uorescent CE-labelled liposomes (5 ml) and unlabelled VLDL acceptors (5 ml),
were incubated at 37°C in a ®nal volume of 200 ml of Tris buffered saline (TBS) (Tris, 10 mmol/l; NaCl, 150 mmol/l, pH 7.4) in 96 well microplates. Changes in uorescence were monitored for a 2 h period using a Victor 2± Ô¯uorescent counter (Perkin Elmer Life Sciences, Boston, MA, USA), with 465 nm excitation and 535 nm emission wavelengths.
Isotopic assay
CE transfer activity was determined by measuring the transfer of radiolabelled CEs from biosynthetically labelled 3 H-CE-low-density lipoprotein (LDL) to unlabelled acceptor high-density lipoprotein (HDL) (Lagrost et al., 1994) . LDL was biosynthetically labelled according to the procedure previously described. Brie¯y, a d > 1.13 g/ml plasma fraction obtained after ultracentrifugation of 20 ml of blood plasma was dialysed against TBS and then incubated for 24 h at 37°C with 10 nmol of [1a, 2a, 3 -H] cholesterol to allow cholesterol esteri®cation by lecithin:cholesterol-acyltransferase. Subsequently, a 1.019 < d < 1.055 g/ml fraction obtained from 10 ml of plasma was added to the incubated mixture. The incubation was then prolonged for 6 h to allow the transfer of radiolabelled CEs from HDL to LDL. Finally, radiolabelled LDL ( 3 H-CE-LDL) was recovered by sequential ultracentrifugation. For the measurement of CE transfer activity, 2.5 nmol of 3 H-CE-LDL and 10 nmol of unlabelled HDL were incubated for 3 h at 37°C in the presence of 10 ml of sample (seminal plasma or blood plasma) in a ®nal volume of 50 ml. Following the incubation, the d < 1.068 g/ml and the d > 1.068 g/ml fractions were separated by ultracentrifugation and the percentage of radioactivity transferred from LDL to HDL was measured. CE transfer activity was calculated as follows:
where T is the CE transfer activity (nmol/ml/h), P( 3 H-CE) is the proportion of labelled CE in the d > 1.068 g/ml fraction, Q t is the total amount of CE present in the LDL per sample (nmol), t is the incubation time (h), v is the volume of plasma added per sample (ml).
Measurement of phospholipid transfer activity
One-phase¯uorescence assay Phospholipid transfer activity was measured using a commercially availablē uorescence activity assay (Cardiovascular targets, New York, NY, USA) following the instructions provided by the manufacturer. The PLTP Activity Kit includes donor and acceptor particles. Incubation of donor and acceptor with PLTP source results in the PLTP-mediated transfer of¯uorescent phospholipid. The¯uorescent phospholipid (NBD-labelled phospholipid) is present in a self-quenched state when associated with the donor. PLTPmediated transfer is determined by the increase in¯uorescence intensity as thē uorescent lipid is removed from the donor and transferred to the acceptor. Brie¯y, plasma samples (5 ml),¯uorescent-labelled donors (3 ml) and unlabelled acceptors (50 ml), were incubated at 37°C in a ®nal volume of 100 ml of TBS in 96 well microplates. Changes in¯uorescence were monitored every minute using a Victor 2± Ô¯uorescent counter (PerkinElmer Life Sciences) for a 30 min period, with a 465 nm excitation and a 535 nm emission wavelength. PLTP activity in seminal plasma (increase in¯uores-cence) was calculated as the increase in¯uorescence between 0 and 20 min. Initial phospholipid transfer rates (increase in¯uorescence/min) were calculated by dividing the increase in¯uorescence in the samples between 0 and 5 min by the incubation time.
Two-phase isotopic and¯uorescence assays
Phospholipid transfer activity was determined as the rate of phospholipid transfer from labelled liposomes toward HDL after selective precipitation of liposomes. Brie¯y, 10 mmol of egg phosphatidylcholine (PC) containing 10 nmol of 14 C-PC ( 14 C-PC-labelled liposomes) or 100 nmol of NBDphosphatidyl-ethanolamine (NBD-PE-labelled liposomes) was dried under a stream of nitrogen and recovered in 1 ml of TBS. 14 C-PC-and NBD-PElabelled liposomes were ®nally obtained by dispersing phospholipids by soni®cation. Samples (20 ml of blood plasma or seminal plasma) were incubated at 37°C for 30 min in the presence of 14 C-PC liposomes or NBD-PE liposomes (125 nmol of phospholipids), human HDL (100 nmol of cholesterol) and iodoacetate (75 nmol) in a ®nal volume of 50 ml in TBS. Phospholipid liposomes were subsequently precipitated by the addition of 350 ml of TBS and 300 ml of a 500 mmol/l NaCl, 215 mmol MnCl 2 , 445 U/ml heparin solution. Successively, tubes were vortexed, left for 10 min at room temperature and ®nally, the precipitate was removed by a 10 min centrifugation at 9000 g in an Eppendorf centrifuge and the supernatant submitted to radioactivity or uorescence counting. Phospholipid transfer activity was calculated after deduction of the blank control value (liposomes and HDL incubated at 37°C without plasma samples) (Lagrost et al., 1994) . Phospholipid transfer activity was calculated as follows:
where T is the phospholipid transfer activity (nmol/ml/h), P(*PL) is the proportion of labelled phospholipid present in the supernatant, Q t is the total amount of phospholipid present in the liposomes per sample (nmol), t is the incubation time (h), v is the volume of plasma added per sample (ml). Speci®c phospholipid transfer activity (nmol/mg/h) is calculated by dividing the phospholipid transfer activity by PLTP concentration.
Measurement of PLTP concentration by enzyme-linked immunosorbent assay (ELISA)
PLTP concentrations were determined using a competitive ELISA adapted to a Biomek 2000Ô Laboratory Automation Workstation (Beckman, Palo Alto, CA, USA.) as previously described (Desrumaux et al., 1997) . The antibody was a polyclonal PLTP antiserum that was obtained by injecting a rabbit with synthetic PLTP fragments.
Western blot analysis
After treatment in non reducing conditions, the samples were resolved by 10% SDS±PAGE and transferred onto a nitrocellulose membrane (HybondÔ; Amersham-Pharmacia Biotech, Freiburg, Germany). After blocking for 1 h with 5% fat-free dry milk, the resulting blots were developed by successive incubations with speci®c primary antibodies (1h) and horseradish peroxydasecoupled second antibodies (1/3000) (1 h). All incubations were performed in phosphate buffer saline (PBS) (Na 2 HPO 4 , 80 mmol/l; NaH 2 PO 4 , 20 mmol/l; NaCl, 137 mmol/l, pH 7.4) containing 0.1% (v/v) Tween 20. Finally, the blots were revealed using a chemiluminescent substrate (ECLÔ; AmershamPharmacia Biotech). The antibodies were TP2 mouse monoclonal antibody for CETP (1 mg/ml) (Ottawa Heart Institute Corporation, Canada) and mab 59 monoclonal antibody for PLTP (2 mg/ml).
Gel-®ltration chromatography
200 ml of seminal plasma sample (pooled from four distinct individual samples) were injected on a Superose 6 HR 10/30 column (Amersham-Pharmacia Biotech). Elution was performed at a 0.3 ml/min¯ow rate with PBS. Fractions of 0.6 ml were collected and PLTP activity as well as cholesterol and protein concentrations were assessed in individual fractions. Molecular weights were obtained by comparison with protein standard.
Puri®cation of prostasomes
Prostasomes were puri®ed as described previously (Arienti et al., 1999) . Brie¯y, seminal plasma was centrifuged at 10 000 g for 20 min, the supernatant collected and submitted to a second round of centrifugation (105 000 g for 90 min). The resulting pellet was then collected, resuspended in TBS and puri®ed by gel-®ltration chromatography.
Statistical analysis
Mann±Whitney U-test was used to determine the signi®cance between data means. Signi®cance was assumed when P < 0.05.
Results
Lack of CE transfer activity in human seminal plasma
The ability of blood and seminal plasmas to promote the transfer of CE was studied using a¯uorescence assay that measured the transfer of labelled CE from liposomes to unlabelled VLDL acceptors (see Materials and methods). Figure 1 shows typical CE transfer curves that were obtained with blood and seminal plasma samples from one healthy subject. As predicted from a number of previous studies, blood plasma showed a time-dependent CE transfer that developed gradually over the 2 h incubation at 37°C (Figure 1 ). In contrast, no signi®cant CE transfer activity was detected in seminal plasma under identical incubation conditions (Figure 1 ). Consistent observations were made with seminal plasma samples from 10 different men (healthy volunteers and men consulting at the centre of sterility). The same conclusions were drawn with an independent isotopic transfer assay that measured the rate of transfer of radiolabelled CEs from LDL donors to unlabelled HDL acceptors (results not shown). In accordance with the lipid transfer measurements, the lack of CETP in seminal plasma was con®rmed by Western blot analysis using a speci®c monoclonal CETP antibody (Figure 2) .
Presence of phospholipid transfer activity in human seminal plasma
The ability of blood and seminal plasma to promote the transfer of phospholipids was investigated using a one-phase¯uorescence assay that measured the transfer of labelled phospholipid from liposomes to unlabelled acceptors (see Materials and methods). Blood plasma showed high phospholipid transfer activity. After only 5 min, the transfer rate decreased probably due to equilibration of thē uorescent-labelled phospholipids between donor and acceptor particles (Figure 3) . In contrast to CE transfer activity that was detected only in blood plasma, signi®cant phospholipid transfer activity levels were also measured in seminal plasma samples, with a gradual rise in¯uorescence that was observed across the 20 min incubation period studied (Figure 3) . Based on the initial phospholipid transfer rates (Figure 3) , phospholipid transfer activity was~5-fold weaker in seminal plasma than in blood plasma from the same healthy subject. The latter observation was con®rmed using an isotopic transfer assay that measured the transfer of 14 C-PC from liposomes towards unlabelled HDL mediated by seminal plasma from 30 different men consulting at the centre of sterility (Table I ). The mean transfer value in seminal plasma was 179 T 62 nmol/ml/h, agaiñ 20% of the values previously measured in blood plasma of normolipidemic subjects with the same isotopic assay and in the same laboratory (Desrumaux et al., 1997) .
Western blot analysis of blood and seminal plasma samples was conducted using a speci®c anti-PLTP antibody. As shown in Figure 4 , both seminal and blood plasma displayed homogeneous,~80 kDa bands that correspond to the predicted molecular weight of the mature, glycosylated form of human PLTP (80 kDa) (Huuskonen et al., 1998) . Immunoassay further supported the latter view, and the mean PLTP concentration in seminal plasma as measured by ELISA was 1.51 T 1.50 mg/l,~25% of the mean concentration found in normal blood plasma with the same immunoassay (Desrumaux et al., 1997) . When speci®c phospholipid transfer activities in blood and seminal plasma samples were calculated as the ratio of phospholipid transfer activity to PLTP concentration, similar values were obtained (i.e.~100 nmol/ h/mg), indicating that PLTP from either source are functionally identical.
Determination of the relative contribution of PLTP to phospholipid transfer activity in seminal plasma
Not only PLTP, but other phospholipid-binding proteins likely to be involved in phospholipid exchange reactions in seminal plasma (Desnoyers and Manjunath, 1992) . In order to evaluate the relative contribution of PLTP to this process, the effect of its blockade by either a 60 min, 56°C heating step or anti-PLTP polyclonal antibody on total phospholipid transfer activity of seminal plasma was investigated. As shown in Figure 5 , preheating of seminal plasma for 1 h at 56°C inhibited PC transfer activity by 75%. Preincubation of seminal plasma with anti-PLTP polyclonal antibody produced an 80% inhibition as compared with samples treated with control antibody (non-immune rabbit immunoglobulins) ( Figure 5 ). In order to assess whether seminal PLTP is also able to transfer other phospholipid molecules (i.e. PE), the ability of anti-PLTP polyclonal antibody to inhibit the transfer of PE induced by seminal plasma was measured. An 80% inhibition of the transfer of PE was observed, indicating that PLTP present in seminal plasma is also able to transfer other phospholipid molecules ( Figure 5 ).
Distribution of PLTP in seminal plasma
A pool of four seminal plasma samples was fractionated by gelpermeation chromatography on a Superose 6-HR column (see Materials and methods). Cholesterol and protein concentrations as well as PLTP activity were measured in eluted fractions. As shown in Figure 6 , the majority of cholesterol and PLTP activity coeluted in early fractions that contained large, protein-poor components with an apparent molecular weight >600 kDa. On the basis of structural and compositional analyses (high cholesterol content and high molecular weight), the components of the earlier, PLTP-containing fraction present the main features of prostasomes that have been previously characterized in seminal plasma (Ronquist and Brody, 1985; Arienti et al., 1999) . These data suggest that PLTP is associated with prostasomes and not with HDL 3-like particles that were previously characterized in seminal plasma (Grizard et al., 1992) .
In order to con®rm these results, prostasomes were isolated by centrifugation and gel-®ltration chromatography as previously described (Arienti et al., 1999) . The presence of PLTP in the prostasome-containing fraction was assessed by Western blot analysis. As shown in Figure 7 , PLTP was detected in the prostasome fraction con®rming that seminal PLTP is at least partially associated with prostasomes. In contrast to what was observed with gel-®ltration chromatography, signi®cant amounts of PLTP were also retrieved in the fraction deprived of prostasomes. uorescent-phospholipid labelled liposomes (3 ml) and unlabelled acceptors (50 ml) were incubated at 37°C in a ®nal volume of 100 ml of TBS in 96 well microplates. Changes in¯uorescence were monitored for a 20 min period as described in Materials and methods. Each point represents the mean T SD of triplicate determinations (*, signi®cantly different from blank and seminal plasma samples, P < 0.05, Mann±Whitney; +, signi®cantly different from blank and blood plasma samples, P < 0.05, Mann±Whitney). Figure 2 . Anti-CETP Western blot analysis of human seminal plasma samples. Samples from healthy volunteers [seminal plasma, 2 ml (~50 mg of protein); blood plasma, 0.5 ml (~25 mg of protein); partially puri®ed CETP (10 ng of protein)] were submitted to PAGE on 10% gels and blotted onto nitrocellulose membranes. The resulting blot was successively incubated with TP1 anti-CETP antibody, anti-mouse IgG peroxydase-conjugated immunoglobulins and ®nally revealed using a chemiluminescent substrate. The samples are: 1, molecular weight markers; 2, blood plasma; 3, puri®ed CETP; 4 and 5, seminal plasma.
Relationship of PLTP activity to sperm parameters
Seminal plasma is a complex biological¯uid with testicular, epididymal, prostatic and seminal vesicle secretions contributing to its ®nal composition. In a ®rst attempt to evaluate whether seminal PLTP secretion can be attributed to speci®c tissue sites, PLTP activity in seminal plasma samples was compared with accessory sex gland secretion markers, including fructose as a seminal vesicle marker, zinc as a prostatic marker and a-glucosidase as an epididymal marker. The number of sperm cells was used as a marker of exocrine testicular function. Two-group comparisons of PLTP activity levels were conducted after the population studied was divided in two distinct groups (`normal' versus`abnormal') according to the WHO standards (i.e. abnormal fructose <13 mmol/ejaculate; abnormal zinc <2.4 mmol/ ejaculate; abnormal a-glucosidase <20 mIU/ejaculate; abnormal spermatozoa <40 millions/ejaculate). No statistically signi®cant differences were observed between the`normal' and`abnormal' subgroups for a-glucosidase, zinc and number of sperm cells. In contrast, PLTP activity was signi®cantly higher in the samples with low fructose values as compared with samples with normal fructose values (P < 0.05) ( Table II) . Seminal samples were obtained from men consulting at the centre of sterility. PLTP concentration was determined by speci®c ELISA as described in Materials and methods. PLTP activity was obtained by measuring the transfer of 14 C-PC from radiolabelled liposomes to unlabelled HDL acceptors. Figure 4 . Anti-PLTP Western blot analysis of human seminal plasma samples. Samples from healthy volunteers [seminal plasma, 2 ml (~50 mg of protein); human plasma, 0.5 ml (~25 mg of protein) and partially puri®ed PLTP (4 ng of protein)] were treated as described in Materials and methods. The samples were resolved by 10% SDS±PAGE and ®nally blotted onto nitrocellulose membrane. The resulting blots were successively incubated with monoclonal PLTP antibody, anti-mouse IgG peroxydase-conjugated immunoglobulins and ®nally revealed using a chemiluminescent substrate. The samples are: 1 and 2, seminal plasma; 3, blood plasma; 4, puri®ed PLTP; 5, biotinylated molecular weight markers. Figure 5 . Effect of anti-PLTP polyclonal antibody (A and B) and effect of a pre-heating step (C) on phospholipid transfer activity in human seminal plasma. (A) Mixtures containing 14 C-PC-radiolabelled liposomes, HDL, iodoacetate and seminal plasma from one healthy volunteer (10 ml) were incubated at 37°C in a ®nal volume of 100 ml in the presence of polyclonal PLTP antibody (100 mg) (`+ anti-PLTP antibody' samples) or in the presence of control immunoglobulins (100 mg) (`control' samples). Phospholipid transfer activity was determined as described in Materials and methods. Each bar represents the mean T SD of triplicate determinations (*, signi®cantly different from control sample, P < 0.05, Mann±Whitney). (B) Mixtures containing NBD-PE-labelled liposomes, HDL, iodoacetate and seminal plasma from one healthy volunteer (10 ml) were incubated at 37°C in a ®nal volume of 100 ml in the presence of polyclonal PLTP antibody (100 mg) (`+ anti-PLTP antibody' samples) or in the presence of control immunoglobulins (100 mg) (`control' samples). Phospholipid transfer activity was determined as described in Materials and methods. Each bar represents the mean T SD of triplicate determinations (*, signi®cantly different from control sample, P < 0.05, Mann±Whitney). (C) Mixtures containing 14 C-PC-radiolabelled liposomes, HDL and iodoacetate were incubated at 37°C in a ®nal volume of 100 ml in the presence of 10 ml of preheated (1 h at 56°C) or non-heated seminal plasma from one healthy volunteer (`heated' and`control' samples respectively). Phospholipid transfer activity was determined after a 30 min incubation period as described in Materials and methods. Each point represents the mean T SD of triplicate determinations (*, signi®cantly different from control sample, P < 0.05, Mann±Whitney).
Discussion
The present study reports for the ®rst time that human seminal plasma displays signi®cant phospholipid transfer activity. In contrast, CE transfer activity and CETP were not detectable in human seminal plasma. Although CETP and PLTP were ®rst identi®ed and characterized in blood plasma, their presence was recently reported in some other extracellular¯uids, including human follicular¯uid for CETP (Ravnik et al., 1992) and human cerebrospinal¯uid for PLTP (Demeester et al., 2000) . In contrast to CETP production that is restricted to a relatively limited number of organs or cell types (Drayna et al., 1987) , PLTP displays a wider spectrum of expression, with signi®cant amounts of PLTP reported in ovary, placenta and testis (Albers et al., 1995) . In the present study, signi®cant amounts of phospholipid transfer activity could be measured in all seminal plasma samples, and the presence of PLTP was con®rmed by Western blot analysis and by speci®c ELISA. Both the activity and the concentration of PLTP in seminal plasma was~25% of those found in blood plasma (Desrumaux et al., 1997) . Speci®c phospholipid transfer activity was similar in both¯uids, indicating that PLTP from either blood or seminal plasma is functionally equivalent. In addition to PLTP, other speci®c proteins which are susceptible to bind and transport lipids in seminal plasma have been characterized. HE-1, a soluble protein secreted by the epididymis, is able to bind free cholesterol with high af®nity (Kirchhoff et al., 1996; Okamura et al., 1999; Fouchecourt et al., 2000) . Other lipid-binding proteins are the BSP proteins which are small acidic proteins (15±30 kDa), abundant in bovine seminal plasma (Desnoyers and Manjunath, 1992; Moreau et al., 1999; Manjunath and Therien, 2002) . These proteins are able to stimulate phospholipid and cholesterol ef¯ux from sperm cell membranes. They were shown to interact with HDL, just as plasma PLTP does (Moreau et al., 1999) . It was therefore important to determine to what extent PLTP contributes to the phospholipid transfer activity of seminal plasma, one key point for the future assessment of its real physiological impact. In this respect, both heatinactivation of PLTP and speci®c inhibition by polyclonal anti-PLTP antibody brought consistent responses, with up to 80% of the seminal phospholipid transfer activity attributable to PLTP and not to other seminal phospholipid-binding proteins. In these experiments, lipid transfer was measured using exogenous lipid donors and acceptors. Therefore, the ability of seminal PLTP to transfer molecules present in semen (free cholesterol, vitamin E, etc.) associated with endogenous lipidic structures (prostasomes, spermatozoa membranes, etc.) remains to be established. In seminal plasma, lipids are mainly associated in prostasomes and in HDL-like structures (Ronquist and Brody, 1985; Arienti et al., 1999; Grizard et al., 1992) . Prostasomes are vesicular organelles (~200 nm diameter) that are produced by the prostate gland. They contain few proteins, and their lipid moiety shows a high cholesterol to phospholipid ratio (Ronquist and Brody, 1985; Arienti et al., 1999) . HDL-like structures present lower cholesterol to phospholipid ratios than prostasomes, but unlike plasma HDL they are devoid of CEs, apo A-I or apo E (Grizard et al., 1992) . In the present study, gel-®ltration chromatography and Western blot analysis of puri®ed prostasomes revealed that seminal PLTP is partially associated with prostasomes. This localization is in good agreement with known structural properties of plasma PLTP that, unlike CETP, was shown to interact Figure 7 . Anti-PLTP Western blot analysis of puri®ed prostasomes. Puri®ed prostasomes (corresponding to 2 ml of seminal plasma,~1.5 mg of protein) and seminal plasma sample deprived of prostasomes (corresponding to 2 ml of seminal plasma,~50 mg of protein) were analysed by Western blot as described in Materials and methods. 1, puri®ed prostasomes; 2, seminal plasma; 3, biotinylated molecular weight markers. readily with large phospholipid-containing liposomes (Lagrost et al., 1994) . In humans, PLTP is known to be produced by a wide variety of organs and cells (Albers et al., 1995) and the source of seminal PLTP remains to be identi®ed. In a ®rst attempt to investigate whether PLTP is secreted by one or several glands that contribute to seminal plasma production, PLTP activity levels in seminal plasma samples were compared with prostate, epididymis or seminal vesicle markers. PLTP activity was not diminished in seminal plasma samples containing abnormally low amounts of epididymal or prostatic secretions. Only a signi®cant increase in PLTP levels was observed when seminal vesicle secretion was low as assessed by measuring fructose concentration. Since seminal vesicle secretion constitutes the major sperm¯uid, the least dilution of PLTP in a lower volume of a PLTP-free¯uid might account for the observed rise in phospholipid transfer activity. Although the testis was shown to express high levels of PLTP mRNA (Albers et al., 1995) , PLTP activity was not signi®cantly different in patients with oligospermia. However, it cannot be excluded that PLTP of seminal plasma might be produced, at least in part, by testis, and the identi®cation of cell types that are responsible for the testicular production of PLTP will constitute a major step during this quest. Another hypothesis holds that seminal PLTP might derive from blood plasma, as might be the case for albumin (Lindholmer et al., 1974) . However, albumin and PLTP behave differently in this context, in spite of similar molecular weights. Indeed, the substantial levels of PLTP found in seminal plasma,~25% of the levels in blood plasma, are in contrast with the trace amounts of albumin that did not exceed a few per cent of blood plasma levels (Lindholmer et al., 1974) .
The physiological function of seminal PLTP remains to be established and is beyond the scope of the present study. CETP, which is closely related to PLTP (Bruce et al., 1998a; Bruce et al., 1998b) , has been shown to stimulate sperm cell capacitation, that involves a sterol depletion of the spermatozoa membrane (Cross et al., 1998; Flesch and Gadella, 2000) . Interestingly, PLTP is also able to stimulate cellular cholesterol ef¯ux (Nishida et al., 1997) , and its implication in inter lipoprotein cholesterol and phospholipid exchanges has been clearly established (Wolfbauer et al., 1999) . Therefore, it is tempting to speculate that, like BSP proteins and CETP (Ravnik et al., 1992; Manjunath and Therien, 2002) , PLTP may be involved in the capacitation process. PLTP may either inhibit or stimulate capacitation, depending on the presence of cholesterol donors or acceptors.
In fact, PLTP is a multifunctional protein and transfers a number of amphipathic compounds, including not only phospholipids and unesteri®ed cholesterol, but also diacylglycerides, lipopolysaccharides and a-tocopherol, i.e. the main isomer of vitamin E (Desrumaux et al., 1998; Jiang et al., 2002) . Interestingly, it has long been recognized that spermatogenesis and sperm cells are highly sensitive to vitamin E depletion (Bensoussan et al., 1998; Therond et al., 1996) and signi®cant decreases in total antioxidant capacity of seminal plasma were associated with infertility in humans (Lewis et al., 1999) . Recently, PLTP was shown to exchange vitamin E between plasma lipoproteins and cells, leading to substantial alterations in the antioxidant defences of lipid structures (Desrumaux et al., 1998; Jiang et al., 2002) . If such a PLTP-mediated vitamin E transfer process was also proven to occur in seminal plasma, PLTP might well arise as an important factor in the control of the a-tocopherol content of sperm cell membranes. These two hypotheses will need further investigation. Finally, it remains possible that PLTP functions in the testis or in accessory organs and has no physiological role in seminal plasma. In this case, seminal phospholipid transfer activity and PLTP itself could be considered as functional markers of testis or accessory sex glands.
